Valera Crossword Puzzle

12345678910
Across
  1. 3. GLP1 & GIP are exampple of _____ hormone
  2. 5. Evogliptin reaches ______ state concentration within 3 days of therapy
  3. 7. In Valera M we have used ____ technology
  4. 8. As per a recently published data on 29000 Type 2 Diabetes patients, there was _______ fold increased risk of CVD with high Glycaemic Variability.
  5. 9. With the help of _______ test we can measure Glycaemic variability
  6. 10. Galvas contains_______
Down
  1. 1. Evogliotin shows >80% DPP4 ______ at the end of 24 hours also
  2. 2. Valera can be safely prescribed in renal patients until the _____ in 15 ml/min.
  3. 4. Glycaemic Variability is one of the major concern for Diabetes related ______
  4. 6. As per _______ India study, Evogliptin 5 mg was effective, safe and non-inferior to Sitagliptin as an add on therapy to Metformin 1000mg in Indian patients with T2DM.
  5. 8. is the brand of Linagliptin by Boheringer Ingelheim
  6. 9. Evogliptin is found safe in _____ patients because it is excreted majorly by hepatic